Results for tag: "Sacubitril"

Sacubitril is a cardiovascular drug used to treat heart failure. It is a neprilysin inhibitor, meaning it works by blocking the action of an enzyme that breaks down certain hormones in the body, allowing them to remain active and help the heart pump more efficiently. Sacubitril is usually prescribed in combination with another drug, valsartan, to reduce the risk of hospitalization and death due to heart failure. It is available in tablet form and is taken twice daily. Sacubitril is a relatively new drug, having been approved by the US Food and Drug Administration in 2015. It has been shown to be effective in reducing the risk of hospitalization and death due to heart failure, and is generally well-tolerated. The Sacubitril market is highly competitive, with several major pharmaceutical companies offering the drug. These include Novartis, AstraZeneca, and Mylan. Other companies, such as Teva Pharmaceuticals and Sandoz, also offer generic versions of the drug. Show Less Read more